These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

301 related articles for article (PubMed ID: 36091467)

  • 1. Hyaluronic acid-based nano drug delivery systems for breast cancer treatment: Recent advances.
    Jia Y; Chen S; Wang C; Sun T; Yang L
    Front Bioeng Biotechnol; 2022; 10():990145. PubMed ID: 36091467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyaluronan-based Multifunctional Nano-carriers for Combination Cancer Therapy.
    Gao M; Deng H; Zhang W
    Curr Top Med Chem; 2021; 21(2):126-139. PubMed ID: 32962617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Hyaluronic Acid-Based Nanocarrier Incorporating Doxorubicin and Cisplatin as a pH-Sensitive and CD44-Targeted Anti-Breast Cancer Drug Delivery System.
    Yu T; Li Y; Gu X; Li Q
    Front Pharmacol; 2020; 11():532457. PubMed ID: 32982750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor therapy for breast cancer: Focus on tumor-associated macrophages and nanosized drug delivery systems.
    Zhan C; Jin Y; Xu X; Shao J; Jin C
    Cancer Med; 2023 May; 12(10):11049-11072. PubMed ID: 36794651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronic Acid-Based Nanocarriers for Anticancer Drug Delivery.
    Fu CP; Cai XY; Chen SL; Yu HW; Fang Y; Feng XC; Zhang LM; Li CY
    Polymers (Basel); 2023 May; 15(10):. PubMed ID: 37242892
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
    Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
    J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Progress in Nanostructured Smart Drug Delivery Systems for Cancer Therapy: A Review.
    Khan MI; Hossain MI; Hossain MK; Rubel MHK; Hossain KM; Mahfuz AMUB; Anik MI
    ACS Appl Bio Mater; 2022 Mar; 5(3):971-1012. PubMed ID: 35226465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A potential carrier for anti-tumor targeted delivery-hyaluronic acid nanoparticles.
    Cai J; Fu J; Li R; Zhang F; Ling G; Zhang P
    Carbohydr Polym; 2019 Mar; 208():356-364. PubMed ID: 30658811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anticancer therapeutics: targeting macromolecules and nanocarriers to hyaluronan or CD44, a hyaluronan receptor.
    Platt VM; Szoka FC
    Mol Pharm; 2008; 5(4):474-86. PubMed ID: 18547053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Exploring the Potentials of Hyaluronic Acid-coated Polymeric Nanoparticles in Enhanced Cancer Treatment by Precision Drug Delivery, Tackling Drug Resistance, and Reshaping the Tumour Micro Environment.
    Raval H; Bhattacharya S
    Curr Med Chem; 2024 Apr; ():. PubMed ID: 38571347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyaluronic Acid Receptor-Mediated Nanomedicines and Targeted Therapy.
    Ouyang Q; Zhao Y; Xu K; He Y; Qin M
    Small Methods; 2024 Oct; 8(10):e2400513. PubMed ID: 39039982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and application of hyaluronic acid in tumor targeting drug delivery.
    Luo Z; Dai Y; Gao H
    Acta Pharm Sin B; 2019 Nov; 9(6):1099-1112. PubMed ID: 31867159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Facile strategy by hyaluronic acid functional carbon dot-doxorubicin nanoparticles for CD44 targeted drug delivery and enhanced breast cancer therapy.
    Li J; Li M; Tian L; Qiu Y; Yu Q; Wang X; Guo R; He Q
    Int J Pharm; 2020 Mar; 578():119122. PubMed ID: 32035259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug Delivery of Natural Products Through Nanocarriers for Effective Breast Cancer Therapy: A Comprehensive Review of Literature.
    Yap KM; Sekar M; Fuloria S; Wu YS; Gan SH; Mat Rani NNI; Subramaniyan V; Kokare C; Lum PT; Begum MY; Mani S; Meenakshi DU; Sathasivam KV; Fuloria NK
    Int J Nanomedicine; 2021; 16():7891-7941. PubMed ID: 34880614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Facile fabrication of robust, hyaluronic acid-surfaced and disulfide-crosslinked PLGA nanoparticles for tumor-targeted and reduction-triggered release of docetaxel.
    Wang X; Cheng R; Zhong Z
    Acta Biomater; 2021 Apr; 125():280-289. PubMed ID: 33677162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid-based drug nanocarriers as a novel drug delivery system for cancer chemotherapy: A systematic review.
    Salari N; Mansouri K; Valipour E; Abam F; Jaymand M; Rasoulpoor S; Dokaneheifard S; Mohammadi M
    Daru; 2021 Dec; 29(2):439-447. PubMed ID: 34499323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
    Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
    Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hyaluronic Acid-Coated Nanomedicine for Targeted Cancer Therapy.
    Kim K; Choi H; Choi ES; Park MH; Ryu JH
    Pharmaceutics; 2019 Jun; 11(7):. PubMed ID: 31262049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of hyaluronic acid-based mucoadhesive self nanoemulsifying drug delivery system (SNEDDS) of tamoxifen for targeting breast cancer.
    Batool A; Arshad R; Razzaq S; Nousheen K; Kiani MH; Shahnaz G
    Int J Biol Macromol; 2020 Jun; 152():503-515. PubMed ID: 32112841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD44-tropic polymeric nanocarrier for breast cancer targeted rapamycin chemotherapy.
    Zhao Y; Zhang T; Duan S; Davies NM; Forrest ML
    Nanomedicine; 2014 Aug; 10(6):1221-30. PubMed ID: 24637218
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.